Inhibition of prolactin release by serotonin antagonists in hyperprolactinemic subjects. 1978

C Ferrari, and R Caldara, and P Rampini, and P Telloli, and M Romussi, and A Bertazzoni, and G Polloni, and A Mattei, and P G Crosignani

Metergoline (4 mg) and methysergide (3 mg), two serotonin antagonists known to inhibit prolactin secretion in normal subjects, and the dopaminergic agonist, bromocriptine (2.5 mg) were orally administered in hyperprolactinemic patients. Mean serum prolactin concentration was significantly decreased between 120 and 240 min following the ingestion of all three drugs in comparison with a placebo; a consistent reduction to below 50% of basal values occurred in 10 of 14 patients after metergoline, in 5 of 10 after methysergide, and in 11 of 14 after bromocriptine administration. These data indicate that serotonin antagonists may acutely lower serum prolactin levels in hyperprolactinemic patients similarly to bromocriptine, though their mechanism of action is most likely different.

UI MeSH Term Description Entries
D008297 Male Males
D008711 Metergoline A dopamine agonist and serotonin antagonist. It has been used similarly to BROMOCRIPTINE as a dopamine agonist and also for MIGRAINE DISORDERS therapy. Methergoline,Liserdol
D008784 Methysergide An ergot derivative that is a congener of LYSERGIC ACID DIETHYLAMIDE. It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome. Dimethylergometrin,Methylmethylergonovine,Deseril,Desril,Désernil-Sandoz,Methysergide Dimaleate,Methysergide Maleate,Sansert,UML-491,Dimaleate, Methysergide,Désernil Sandoz,Maleate, Methysergide,UML 491,UML491
D010900 Pituitary Diseases Disorders involving either the ADENOHYPOPHYSIS or the NEUROHYPOPHYSIS. These diseases usually manifest as hypersecretion or hyposecretion of PITUITARY HORMONES. Neoplastic pituitary masses can also cause compression of the OPTIC CHIASM and other adjacent structures. Adenohypophyseal Diseases,Hypophyseal Disorders,Neurohypophyseal Diseases,Anterior Pituitary Diseases,Pituitary Disorders,Pituitary Gland Diseases,Posterior Pituitary Diseases,Adenohypophyseal Disease,Anterior Pituitary Disease,Disease, Adenohypophyseal,Disease, Anterior Pituitary,Disease, Neurohypophyseal,Disease, Pituitary,Disease, Pituitary Gland,Disease, Posterior Pituitary,Diseases, Adenohypophyseal,Diseases, Anterior Pituitary,Diseases, Neurohypophyseal,Diseases, Pituitary,Diseases, Pituitary Gland,Diseases, Posterior Pituitary,Disorder, Hypophyseal,Disorder, Pituitary,Disorders, Hypophyseal,Disorders, Pituitary,Hypophyseal Disorder,Neurohypophyseal Disease,Pituitary Disease,Pituitary Disease, Anterior,Pituitary Disease, Posterior,Pituitary Diseases, Anterior,Pituitary Diseases, Posterior,Pituitary Disorder,Pituitary Gland Disease,Posterior Pituitary Disease
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D004873 Ergolines A series of structurally-related alkaloids that contain the ergoline backbone structure. Ergoline
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C Ferrari, and R Caldara, and P Rampini, and P Telloli, and M Romussi, and A Bertazzoni, and G Polloni, and A Mattei, and P G Crosignani
January 1980, Annales d'endocrinologie,
C Ferrari, and R Caldara, and P Rampini, and P Telloli, and M Romussi, and A Bertazzoni, and G Polloni, and A Mattei, and P G Crosignani
December 1982, Life sciences,
C Ferrari, and R Caldara, and P Rampini, and P Telloli, and M Romussi, and A Bertazzoni, and G Polloni, and A Mattei, and P G Crosignani
September 1989, The Journal of clinical endocrinology and metabolism,
C Ferrari, and R Caldara, and P Rampini, and P Telloli, and M Romussi, and A Bertazzoni, and G Polloni, and A Mattei, and P G Crosignani
December 1991, Brain research,
C Ferrari, and R Caldara, and P Rampini, and P Telloli, and M Romussi, and A Bertazzoni, and G Polloni, and A Mattei, and P G Crosignani
January 1979, Hormone research,
C Ferrari, and R Caldara, and P Rampini, and P Telloli, and M Romussi, and A Bertazzoni, and G Polloni, and A Mattei, and P G Crosignani
January 1983, Journal of neural transmission,
C Ferrari, and R Caldara, and P Rampini, and P Telloli, and M Romussi, and A Bertazzoni, and G Polloni, and A Mattei, and P G Crosignani
January 1980, Neuroendocrinology,
C Ferrari, and R Caldara, and P Rampini, and P Telloli, and M Romussi, and A Bertazzoni, and G Polloni, and A Mattei, and P G Crosignani
April 1978, The Journal of clinical endocrinology and metabolism,
C Ferrari, and R Caldara, and P Rampini, and P Telloli, and M Romussi, and A Bertazzoni, and G Polloni, and A Mattei, and P G Crosignani
September 1978, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
C Ferrari, and R Caldara, and P Rampini, and P Telloli, and M Romussi, and A Bertazzoni, and G Polloni, and A Mattei, and P G Crosignani
May 2000, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
Copied contents to your clipboard!